MannKind (MNKD)
Commercializes Afrezza, FUROSCIX and V-Go while manufacturing Tyvaso DPI for United Therapeutics.
$3.44
After hours−0.04 (−1.15%)
At close$3.48(−0.57%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 57.51% | 184.93M shares | |
|---|---|---|---|
| 268 holders · as of Jun 30, 2026 | |||
| Insiders | 2.41% | 7.74M shares | |
| 13 holders · as of Sep 14, 2026 | |||
| Other | 40.08% | 128.87M shares | |
| remainder | |||
321.54M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
268 holders · 184.93M shares · 52 new positions · 146 increased · 65 reduced · 43 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 32.13M | 9.99% | +3.53M | Aug 7, 2026 |
| Rubric Capital Management LP | 18.00M | 5.60% | +14.38M | Aug 14, 2026 |
| State Street Corp | 16.17M | 5.03% | −2.51M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 13.17M | 4.10% | +278.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 7.95M | 2.47% | +442.1K | Aug 12, 2026 |
| Wellington Management Group LLP | 7.84M | 2.44% | +4.56M | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | 6.60M | 2.05% | +700.0K | Aug 14, 2026 |
| Deep Track Capital, LP | 6.00M | 1.87% | +6.00Mnew | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| State Street Corporation | 6.10% | 18.68M | 13G | May 12, 2026 |
| Rubric Capital Management LP | 5.83% | 18.00M | 13G | Aug 14, 2026 |
| Vanguard Capital Management | 5.00% | 15.45M | 13G | Jul 31, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 10, 2026 | Steven B. Binderdirector | Sale | 33,558 | $3.81 | 752,309 |
| Aug 7, 2026 | Steven B. Binderdirector | Sale | 39,051 | $4.06 | 785,867 |
| Jul 17, 2026 | Steven B. Binderdirector | Sale | 52,485 | $4.06 | 824,918 |
| Jul 17, 2026 | David Thomsonofficer: EVP Genl Counsel & Secretary | Sale | 24,109 | $4.05 | 797,554 |
| May 12, 2026 | David Thomsonofficer: EVP Genl Counsel & Secretary | Sale | 3,033 | $3.29 | 826,299 |
| May 12, 2026 | Steven B. Binderdirector | Sale | 16,940 | $3.29 | 808,008 |
| Mar 10, 2026 | Michael Castagnadirector, officer: Chief Executive Officer | Purchase | 100,000 | $2.59 | 2,575,911 |
| Jan 8, 2026 | Stuart A. Trossofficer: Chief People & Workpl Officer | Sale | 47,006 | $6.33 | 985,007 |
| Dec 17, 2025 | Michael Castagnadirector, officer: Chief Executive Officer | Sale | 65,804 | $6.01 | 2,504,792 |
| Dec 16, 2025 | Michael Castagnadirector, officer: Chief Executive Officer | Sale | 21,310 | $6.00 | 2,504,792 |
House and Senate disclosures
Not reported.